WB

Walgreens Boots Alliance, Inc.

Concentrated strategyLong-term holder

Total reported value

$2.2B

Reporting period: 2025-06-30 · Number of holdings: 1

Walgreens Boots Alliance, Inc. disclosed 1 holdings in its latest 13F filing for the period ending 2025-06-30, with total reported value of $2.2B and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
100
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
2
Sizing Uniformity
—

Recent moves

No holding changes this quarter

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1CORCencora INCStock-Healthcare100.00%—-28.01%

Holding changes this quarter

Position changes disclosed by Walgreens Boots Alliance, Inc. for the quarter ending 2025-06-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction

FAQ

What is Walgreens Boots Alliance, Inc. and what type of investor is it?
Walgreens Boots Alliance, Inc. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2025-06-30), the firm manages a tracked equity portfolio valued at approximately $2.2B, spread across 1 disclosed positions.
What are Walgreens Boots Alliance, Inc.'s largest equity positions?
Based on the latest 13F filing, Walgreens Boots Alliance, Inc.'s top holdings by market value are: 1. Cencora INC (COR) — $2.2B (100.0%)
What changes did Walgreens Boots Alliance, Inc. make in its most recent portfolio filing?
No notable portfolio changes were recorded for Walgreens Boots Alliance, Inc. in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Walgreens Boots Alliance, Inc. focus on?
Walgreens Boots Alliance, Inc. is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 100.0%